Asthma Trials in Shenyang, China
Conditions / Asthma / Shenyang, China
Asthma has been the subject of sustained clinical investigation across multiple research sites.
43 total trials for this combination
Showing top 10 of 43 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03052517 | Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment | TERMINATED | PHASE3 |
| NCT06676319 | Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma | RECRUITING | — |
| NCT05763121 | A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. | TERMINATED | PHASE3 |
| NCT04609904 | Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS) | COMPLETED | PHASE3 |
| NCT02555683 | Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. | COMPLETED | PHASE3 |
| NCT06529419 | A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations | COMPLETED | PHASE2 |
| NCT04719832 | Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT06023589 | A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma | RECRUITING | — |
| NCT06307665 | Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma | RECRUITING | — |
| NCT02554786 | A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma | COMPLETED | PHASE3 |